Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMontefiore Medical Center

About this trial

The field of transcatheter tricuspid valve replacement (TTVR) is rapidly emerging and data on this topic are scarce. Particularly, little is known about which patients are at greatest risk of procedural complications, such as the timing and onset of conduction disturbances necessitating permanent pacemaker implantation, and how such patients are managed. On this background, the TRIPLACE Registry - an investigator-initiated global multicenter registry - is aimed at better understanding the safety and efficacy of orthotopic TTVR.

Eligibility criteria

Qualifiers

Patients undergoing Transcatheter Tricuspid Valve Replacement

Native Tricuspid Valve disease

Orthotopic Tricuspid Valve Implantation

Disqualifiers

Age under 18 years

Trial design

Treatments tested in this trial

  • Transcatheter Tricuspid Valve Replacement

Treatment groups

800 Participants
are divided into 1 treatment group

Locations

21
Canada
St. Paul's HospitalV6Z 1Y6, VancouverBritish Columbia, Canada
St Michael's Hospital, University of TorontoM5B 1W8, TorontoOntario, Canada
Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, CanadaG1V 4G5, QuébecQuebec, Canada
Denmark
Rigshospitalet, Copenhagen University Hospital2100, Copenhagen Denmark

Sponsors and collaborators

Montefiore Medical Center

Lead sponsor

The Cleveland Clinic

Collaborator

University of Toronto

Collaborator

University Hospital, Bordeaux

Collaborator